Cue
Financials
Estimates*
| USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 6.6m | 23.0m | 618m | 483m | 64.2m | 57.0m | 110m |
| % growth | - | 246 % | 2593 % | (22 %) | (87 %) | (11 %) | 93 % |
| EBITDA | (16.8m) | (38.8m) | 131m | (201m) | (213m) | - | - |
| % EBITDA margin | (254 %) | (169 %) | 21 % | (42 %) | (332 %) | - | - |
| Profit | (20.6m) | (47.4m) | 86.4m | (194m) | (373m) | - | - |
| % profit margin | (311 %) | (206 %) | 14 % | (40 %) | (582 %) | - | - |
| R&D budget | 21.4m | 28.5m | 42.8m | 171m | 151m | - | - |
| R&D % of revenue | 323 % | 124 % | 7 % | 35 % | 235 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Convertible | ||
$7.5m | Series A | ||
N/A | Seed | ||
$15.5m | Series B | ||
N/A | Convertible | ||
$45.0m | Series B | ||
| N/A | $5.3m | Series A | |
N/A | Series A | ||
$13.7m | Grant | ||
$100m | Series C | ||
$481m | Grant | ||
$235m | Late VC | ||
| N/A | $200m Valuation: $2.3b 100.2x EV/LTM Revenues -59.3x EV/LTM EBITDA | IPO | |
N/A | Grant | ||
| Total Funding | $903m | ||
Related Content
Recent News about Cue
EditCue Health is a digital healthcare startup that provides a comprehensive suite of at-home testing services, telehealth consultations, and personalized treatment plans. The company operates in the rapidly growing digital health market, serving a broad range of clients including individuals seeking to manage their health from the comfort of their homes.
Cue Health's business model revolves around its user-friendly mobile application. The app offers a variety of at-home tests for managing heart health, sexual health, food sensitivities, and more. It also provides an FDA-authorized COVID-19 test that delivers lab-quality results in 20 minutes. The company prides itself on the accuracy of its tests, with its COVID-19 test matching lab results with 97.8% accuracy in an independent study by Mayo Clinic.
In addition to testing, the app connects users with healthcare experts for personalized care and treatment plans. This includes a unique GLP-1 treatment plan for weight loss, complete with one-on-one online support. The company also offers a range of prescription treatments that can be ordered directly through the app, providing a seamless, end-to-end healthcare solution.
Cue Health generates revenue through the sale of its at-home tests, telehealth services, and prescription treatments. The company's mission is to empower individuals to live their healthiest lives by making healthcare and health insights more accessible and actionable.
Keywords: Digital Healthcare, At-Home Testing, Telehealth, Personalized Treatment, Mobile App, Heart Health, Sexual Health, Food Sensitivities, COVID-19 Test, Weight Loss.